Publications by authors named "S Nseir"

Objectives: A post hoc analysis used pooled STRIVE/ReSTORE trial data to determine outcomes with rezafungin versus caspofungin by Candida species and antifungal susceptibility.

Methods: The efficacy and safety of once weekly rezafungin 400/200 mg versus once daily caspofungin 70/50 mg was demonstrated in the randomized, double-blind phase 2 STRIVE (NCT02734862) and phase 3 ReSTORE (NCT03667690) trials involving adults with candidaemia and/or invasive candidiasis. In this analysis, data were pooled for patients with a documented Candida infection within 96 hours of randomization who also received ≥1 dose of study drug.

View Article and Find Full Text PDF

Alpha-1 antitrypsin (A1AT) is the major circulating serine protease inhibitor. Hypersialylated glycoforms (HSG) are produced to boost A1AT anti-inflammatory and anti-protease properties. Their occurrence and prognostic impact outside severe COVID-19 or community-acquired pneumonia are unknown.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates how intestinal colonization with multidrug-resistant Enterobacterales (MDRE-IC) affects the risk of bloodstream infections (nE-BSI) in hospitalized patients, finding that MDRE-IC significantly increases this risk.
  • - Conducted at a large hospital in 2019, the research involved over 7000 patients, with 11.9% found to have MDRE-IC; those colonized had a higher incidence of nE-BSI compared to non-colonized patients.
  • - The results highlight the importance of improving infection control and antibiotic use strategies in hospitals to reduce the risk of bloodstream infections related to MDRE colonization.
View Article and Find Full Text PDF